How to Buy Cue Biopharma Stock [2024]

Summary: Cue Biopharma, a clinical-stage biopharmaceutical company looking to bring a new class of immunotherapies to cancer patients, is publicly listed on the NASDAQ with the ticker CUE, which means you can conveniently buy Cue Biopharma stock with online brokers such as Interactive Brokers.

Best Platform for Worldwide Stock Trading & Investing

Highly trusted multi-asset broker with clients in over 200 countries
Trade on 150 markets globally from a single platform (stocks, ETFs, futures, currencies, crypto & more)
Low commissions starting at $0 with no platform fees or account minimums
Easily fund your account and trade assets in 26 currencies
IBKR pays up to 4.58% interest on cash balances of $10k or more

Up to 4.58% interest on balance*

Get Started

About Cue Biopharma

Cue Biopharma’s homepage. Source: Cuebiopharma.com

Cue Biopharma (NASDAQ: CUE) is a US-based clinical-stage biopharmaceutical company that specializes in the development of injectable biologics designed to selectively engage and modulate tumor-specific T cells within the body to treat cancer and other critical diseases. Their innovative approach is set to revolutionize treatments by avoiding unnecessary immune activation, thereby minimizing potential side effects.

Its primary drug under development is CUE-101, a fusion protein biologic tailored to activate T cells that target HPV-related cancers. The company is also developing CUE-102, aimed at the Wilms’ Tumor 1 protein in multiple cancers, and CUE-103, another product from the CUE-100 series, focusing on the KRAS G12V mutation and the MAGE-A4 cancer antigen. Outside the field of oncology, the company has the Neo-STAT and RDI-STAT initiatives, which include the CUE-200, CUE-300, and CUE-400 series.

Cue Biopharma collaborates with Merck Sharp & Dohme Corp. (NYSE: MRK) on research and development projects for biologics targeting various autoimmune diseases, as well as LG Chem, Ltd. to work on Immuno-STATs with a focus on oncology.

Cue Biopharma is listed on the NASDAQ Exchange under the stock ticker CUE.

How to buy Cue Biopharma stock? Step-by-step process

Here’s a brief guide to buying Cue Biopharma stock:

Select an online broker;
Set up and fund your account;
Purchase CUE shares;
Regularly review your investment and adjust as needed.

Step 1: Choose a broker

To acquire shares of Cue Biopharma, start by selecting a reliable online broker. By our analysis, Interactive Brokers emerges as a leading choice, offering:

Commission-free stock trading;
Global stock-trading on 90+ market centers;
Fractional shares available;
Extra income on fully paid shares;
Lowest financing rates for margin accounts in the industry;
No account minimum.

Best Platform for Worldwide Stock Trading & Investing

Highly trusted multi-asset broker with clients in over 200 countries
Trade on 150 markets globally from a single platform (stocks, ETFs, futures, currencies, crypto & more)
Low commissions starting at $0 with no platform fees or account minimums
Easily fund your account and trade assets in 26 currencies
IBKR pays up to 4.58% interest on cash balances of $10k or more

Up to 4.58% interest on balance*

Get Started

For those looking to steer away from the high-risk nature of biotech penny stocks, here are a few well-established biotech companies worth considering:

Pfizer (NYSE: PFE);
Moderna (NASDAQ: MRNA);
Sanofi (NASDAQ: SNY);
Eli Lilly (NYSE: LLY);
Biogen (NASDAQ: BIIB);
Amgen (NASDAQ: AMGN);
Gilead Sciences (NASDAQ: GILD);
Bayer (FWB: BAYN);
Thermo Fisher Scientific (NYSE: TMO).

How to choose the best online broker?

In your quest for the right online broker, keep these considerations in mind:

Product offerings: Ensure they provide access to the Nasdaq Exchange and CUE in particular, as well as any other asset types that might interest you;
Fee structure: Familiarize yourself with their pricing and be vigilant about potential undisclosed fees;
Regulation & Security: Ensure they are regulated by the appropriate financial institutions and have robust safety measures to protect both your investments and personal information;
Fractional shares: Verify if the broker supports investing in fractional shares, beneficial for budget-conscious investors or those keen on a dollar-cost averaging approach.

Step 2: Open and fund your account

After choosing your broker, sign up on their website or app. Once verified, you can deposit funds using your preferred funding method—bank transfers, credit cards, or other payment options.

Step 3: Place your order and invest in CUE

Follow these steps to buy Cue Biopharma stock:

Find Cue Biopharma using its ticker symbol CUE;
Decide on the order type—whether a market order for immediate purchase or a limit order to buy at a specific price;
Specify your investment amount, either in dollar terms or by share count;
Review all details before confirming the purchase.

Step 4: Monitor your investment

Once you’ve secured your position in Cue Biopharma, it’s essential to stay informed:

Utilize tools like Google Alerts to receive news related to “Cue Biopharma” or other related keywords;
On your brokerage or financial app, set up price alerts for CUE to be informed of significant price movements;
Use the analytical tools your broker offers;
Stay aware of broader trends in the biotechnology sector;
Regularly review the company’s financial reports for insights on performance and future directions.

Cue Biopharma stock price today

Pros and cons of investing in Cue Biopharma

Pros

Innovative approach: Biopharmaceutical companies like Cue Biopharma often focus on pioneering treatments, which, if successful, can revolutionize specific areas of medicine;
Potential market leadership: If one of their drug candidates receives approval and addresses an unmet medical need, it can lead to significant revenue;
Collaborations and partnerships: Cue Biopharma has entered into partnerships with larger pharmaceutical firms, which can validate their approach and provide crucial financial support;
Long-term potential: If any of their drug candidates move into later-stage clinical trials and show promise, it can boost the company’s stock value;
Intellectual property: Owning patents or exclusive rights to specific treatments can offer competitive advantages and potential licensing revenue.

Cons

High risk: The biopharmaceutical industry is fraught with risks. Many drug candidates fail during clinical trials;
Regulatory hurdles: Even if a drug shows promise, it needs to pass stringent regulatory hurdles before it can be sold;
Competition: The sector is highly competitive, with many companies vying for the next breakthrough;
Financial stability: Smaller biopharmaceutical firms often operate at a loss and require continuous capital to fund research. There’s a risk of dilution for existing shareholders if the company issues more stock;
Dependency on few products: Many biopharmaceutical companies, especially smaller ones, have a pipeline dependent on a limited number of products. If one fails, it can significantly impact the company’s valuation;
Penny stock volatility: As a penny stock, Cue Biopharma is inherently speculative and high-risk

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

FAQs about how to buy Cue Biopharma stock